NCT04836169View on ClinicalTrials.gov

Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy

NAUnknownINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

October 31, 2021

Primary Completion Date

April 30, 2022

Study Completion Date

May 31, 2022

Conditions
Pain, PostoperativeAnalgesics, Opioid
Interventions
DEVICE

InCaveo's EOA system with integrated mobile CBT

integrated pain management therapeutic and tapering system including a software apt that manages and tracks patient-reported outcomes, including pain levels, medication use, quality of life

Sponsors

Lead Sponsor

InCaveo
All Listed Sponsors
lead

InCaveo

INDUSTRY

NCT04836169 - Phase 1: Randomized Evaluation of a System to Deliver Mobile Cognitive Behavioral Therapy | Biotech Hunter | Biotech Hunter